Valvular Assessment of New Generation Aortic Replacement Devices
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT06688448
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT06688448
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT06688448. Randomized; no masking; primary purpose treatment. Start 2024-12-01 (actual); primary completion 2026-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Valvular Assessment of New Generation Aortic Replacement Devices
- Acronym
- VANGUARD
- Condition
- Aortic Regurgitation Disease
- Condition
- Aortic Valve Calcification
- Condition
- Bicuspid Aortic Valve Disease
- Intervention (Device)
- Dafodil prosthesis
- Intervention (Device)
- Aortic Valve Replacement - Inspires Resilia prosthesis
- Lead sponsor
- Instituto Dante Pazzanese de Cardiologia
Record details
- Record id
cardio:ct-nct06688448- Content hash
339cfa8fae439f94ae3091a84bf037dfdcc5328c9023a4e7df3a40f4c55ca0a0